Eunice Wang, MD of Roswell Park Comprehensive Cancer Center Genetic speaks about Testing + AML: New Resource to Bridge the Gap.
Link to Be AML Ready –
https://www.beamlready.com/hcp
In patients with AMLL with relapsed or refractory (R/R)
Results of genetic testing help guide treatment decisions
For patients and their caregivers, acute myeloid leukemia (AML) can be devastating, especially for those who have relapsed or are refractory to treatment. A critical component of having these patients ready for the journey ahead is genetic testing, as it can detect newly acquired mutations and finally inform a suitable and possibly tailored treatment plan.
We hope that you’ll share this advice with your community after you take the time to consider the emerging R/R AML testing and treatment paradigm.